PuraPharm Corp. Plans Major Capital Restructuring

PuraPharm Corp. Ltd. (HK:1498) has released an update.

PuraPharm Corp. Ltd. is set to hold an extraordinary general meeting to discuss a significant capital restructuring. The proposed changes include reducing the par value of its shares and increasing the number of authorized shares, aiming to offset accumulated losses and create a more robust financial position. This strategic move could potentially enhance the company’s market standing and investor appeal.

For further insights into HK:1498 stock, check out TipRanks’ Stock Analysis page.